Clinical Trial Update: Clinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe Sepsis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating fish oil–based lipid emulsion infusions in critically ill patients with severe sepsis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Fish oil-based lipid emulsion (omega-3 fatty acid lipid emulsion)

Snippet

Sponsor: Li Shin Hospital | Conditions: Severe Sepsis | Phase 4 | Status: COMPLETED